C-reactive protein and incident coronary heart disease in the Atherosclerosis Risk In Communities (ARIC) study

American Heart Journal

Volumn 144, Issue 2, 2002, Pages 233-238

  Folsom, Aaron R ^a   Aleksic, Nena ^b   Catellier, Diane ^c   Juneja, Harinder S ^b   Wu, Kenneth K ^b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c IL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN; INTERCELLULAR ADHESION MOLECULE 1;

ADULT; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE MARKER; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RISK FACTOR;

EID: 0036342394     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1067/mhj.2002.124054     Document Type: Article

References (44)

1. Low grade inflammation and coronary heart disease: Prospective study and updated meta-analysis
2. C-reactive protein as a cardiovascular risk factor: More than an epiphen-omenon?
3. Interferon-γ and lipopolysaccharide potentiate monocyte tissue factor induction by C-reactive protein: Relationship with age, sex, and hormone replacement treatment
4. C-reactive protein-mediated low density lipoprotein uptake by macrophages: Implications for atherosclerosis
5. Direct proinflammatory effect of C-reactive protein on human endothelial cells
6. Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease
7. Prospective study of hemostatic factors and incidence of coronary heart disease: The Atherosclerosis Risk in Communities (ARIC) Study
8. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: Meta-analyses of prospective studies
9. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men
10. Elevation of tumor necrosis factor-γ and increased risk of recurrent coronary events after myocardial infarction
11. 2 as an independent predictor of coronary heart disease
12. Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study: Multiple Risk Factor Intervention Trial
13. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
14. Relationship of C-reactive protein to risk of cardiovascular disease in the elderly: Results from the Cardiovascular Health Study and the Rural Health Promotion Project
15. C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: Results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992
16. Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly
17. Von Willebrand factor, C-reactive protein, and 5-year mortality in diabetic and nondiabetic subjects: The Hoorn Study
18. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women
19. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women
20. Infections, inflammation, and the risk of coronary heart disease
21. Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events
22. Tissue-type plasminogen activator and C-reactive protein in acute coronary heart disease: A nested case-control study
23. C-reactive protein, fibrin D-dimer, and incident ischemic heart disease in the Speedwell Study: Are inflammation and fibrin turnover linked in pathogenesis?
24. The Atherosclerosis Risk in Communities (ARIC) Study: Design and objectives
25. A short questionnaire for the measurement of habitual physical activity in epidemiological studies
26. High resolution B-mode ultrasound reading methods in the Atherosclerosis Risk in Communities Study (ARIC)
27. Gerinnungsphysiologische schnellmethode zur bestimmung des fibrinogens
28. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
29. Community surveillance of coronary heart disease in the Atherosclerosis Risk in Communities (ARIC) Study: Methods and initial two years' experience
30. Variability in the measurement of C-reactive protein in healthy subjects: Implications for reference intervals and epidemiological applications
31. Robust variance estimation for the case-cohort design
32. Tests for trend in life table analysis
33. Comparison of baseline and repeated measure covariate techniques in the Framingham Heart Study
34. A prospective study of coronary heart disease in relation to fasting insulin, glucose, and diabetes: The Atherosclerosis Risk in Communities (ARIC) Study
35. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: The Atherosclerosis Risk in Communities (ARIC) Study 1987-1993
36. Carotid atherosclerosis measured by B-mode ultrasound in populations: Associations with cardiovascular risk factors in the ARIC study
37. Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: The Atherosclerosis Risk in Communities (ARIC) Study
38. High-sensitivity C-reactive protein: Potential adjunct for global risk assessment in the primary prevention of cardiovascular disease
39. Association of C-reactive protein with markers of prevalent atherosclerotic disease (the NHLBI Family Heart Study)
40. Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects
41. Associations of C-reactive protein with measures of obesity, insulin resistance, and subclinical atherosclerosis in healthy, middle-aged women
42. Lack of association of C-reactive protein and coronary calcium by electron beam computed tomography in postmenopausal women: Implications for coronary artery disease screening
43. C-reactive protein is not associated with the presence or extent of calcified subclinical atherosclerosis
44. Novel risk factors for systemic atherosclerosis: A comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease